The complex challenges of HIV vaccine development require renewed and expanded global commitment

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The Lancet (British edition) 2020-02, Vol.395 (10221), p.384-388
Hauptverfasser:	Bekker, Linda-Gail, Tatoud, Roger, Dabis, Francois, Feinberg, Mark, Kaleebu, Pontiano, Marovich, Mary, Ndung'u, Thumbi, Russell, Nina, Johnson, Jeremiah, Luba, Maureen, Fauci, Anthony S, Morris, Lynn, Pantaleo, Giuseppe, Buchbinder, Susan, Gray, Glenda, Vekemans, Johan, Kim, Jerome H, Levy, Yves, Corey, Lawrence, Shattock, Robin, Makanga, Michael, Williamson, Carolyn, Dieffenbach, Carl, Goodenow, Maureen M, Shao, Yiming, Staprans, Silvija, Warren, Mitchell, Johnston, Margaret I
Format:	Artikel
Sprache:	eng
Schlagworte:	Acquired immune deficiency syndrome AIDS AIDS Vaccines Antibodies Clinical trials Dengue fever Drug Development - methods Epidemics Epidemics - prevention & control Health Services Accessibility - organization & administration HIV HIV Infections - prevention & control Human immunodeficiency virus Humans Immune clearance Immune system Immunization Immunotherapy International Cooperation Lymphocytes T Malaria Manufacturing Marketing of Health Services Prevention Research facilities Vaccine development Vaccines Viral diseases
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!